RLYB
Rallybio
$16.75
−$0.22 (−1.3%)Sep 10, 2026
Key metrics
The numbers that frame RLYB today
- Market cap
- $88.95M
- P/E (TTM)
- 2.0
- EV / FCF
- -0.1
- Gross margin
- 100%
- EV / Sales
- -6.0
- ROIC
- 272.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.67
- 52wk High
- $17.57
Growth
Revenue and earnings trend for RLYB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RLYB
Is Rallybio a good buy?
Yes. Rallybio has excellent momentum, and it outweighs the poor quality here. Growth looks excellent, which supports the long-term business case.
What is the market capitalization of RLYB?
Rallybio's market capitalization is $88.95M.
What is the P/E ratio for RLYB stock?
Rallybio's current P/E ratio is 2.
What is the 52-week high for RLYB stock?
The 52-week high for Rallybio is $17.57. The current close of $16.75 is 4.7% below that high.
What is the 52-week low for RLYB stock?
The 52-week low for Rallybio is $3.67. The current close of $16.75 is 356.4% above that low.
Does RLYB stock pay dividends?
Rallybio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RLYB?
Rallybio's Debt / Equity ratio is 0.